Navigation Links
Omnicell Announces Second Quarter 2012 Results
Date:8/1/2012

cally reported non-GAAP results to the investment community, we believe the inclusion of non-GAAP numbers provides consistency and enhances investors' ability to compare our performance across financial reporting periods;

3) These non-GAAP financial measures are employed by Omnicell's management in its own evaluation of performance and are utilized in financial and operational decision making processes, such as budget planning and forecasting; and

4) These non-GAAP financial measures facilitate comparisons to the operating results of other companies in our industry, which use similar financial measures to supplement their GAAP results, thus enhancing the perspective of investors who wish to utilize such comparisons in their analysis of our performance.

Set forth below are additional reasons why share-based compensation expense related to ASC 718 is excluded from our non-GAAP financial measures:

i)  While share-based compensation calculated in accordance with ASC 718 constitutes an ongoing and recurring expense of Omnicell, it is not an expense that requires cash settlement by Omnicell. We therefore exclude these charges for purposes of evaluating core operating results. Thus, our non-GAAP measurements are presented exclusive of stock-based compensation expense to assist management and investors in evaluating our core operating results.

ii) We present ASC 718 share-based payment compensation expense in our reconciliation of non-GAAP financial measures on a pre-tax basis because the exact tax differences related to the timing and deductibility of share-based compensation, under ASC 718 are dependent upon the trading price of Omnicell's common stock and the timing and exercise by employees of their stock options.  As a result of these timing and market uncertainties the tax effect related to share-based compensation expense would be inconsistent in amount and frequency and is therefore excluded from our non-GAAP results.


'/>"/>
SOURCE Omnicell, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. University of South Alabama Health System Selects Omnicell G4 Solutions
2. Omnicell to Release Second Quarter 2012 Earnings Results on August 1
3. Omnicell Repeats Best in KLAS Award for OmniRx Automated Medication Dispensing System
4. Actinium Pharmaceuticals Announces The Addition of The Fred Hutchinson Cancer Research Center To Actiniums Multicenter Clinical Trial For Patients With Acute Myeloid Leukemia
5. Oclaro Announces Fourth Quarter and Fiscal Year 2012 Financial Results
6. Life Technologies Announces Second Quarter 2012 Results
7. The Partnership at Drugfree.org Announces New Partners in National Medicine Abuse Action Campaign
8. Heart IT Announces Record Sales for 1st Half of 2012
9. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
10. Omeros Announces Discovery in MASP-2 Program
11. Cell Therapeutics Announces Institutional Investor Purchased Additional $15 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013 Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it will ... March 31, 2013, before market on Tuesday, May 28, 2013.  ... 28, 2013, at 8:00 a.m. EDT (May 28, 2013 at ... results and provide an update on recent corporate developments. ...
(Date:5/16/2013)... , May 17, 2013 ... and Switzerland,s Cytos Biotechnology AG today ... a Phase 1 clinical trial with their H1N1 influenza vaccine ... technology. In this first Phase 1 clinical trial, the safety ... to protect against H1N1 influenza infection will be evaluated. ...
(Date:5/16/2013)...  PTC Therapeutics, Inc., today announced that it has ... U.S. Securities and Exchange Commission ("SEC") relating to the ... number of shares to be offered and the price ... (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) J.P. ... managers for the offering. Cowen and Company is acting ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... Mich., Jan. 23, 2012 Perrigo Company (Nasdaq: PRGO;TASE) announced ... Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine ... the owner of the New Drug Application (NDA) of its ... Impax Laboratories, Inc. (Nasdaq: IPXL ), who will ...
... (OTC: PLCSF), a company focused on innovative medical device ... in the CIN-RG trial, the company,s pivotal trial to ... System™ in the prevention of Contrast-Induced Nephropathy (CIN).  This ... regulatory approval by the U.S. Food and Drug Administration ...
Cached Medicine Technology:Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals 2Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals 3First Patient Treated in PLC Systems' RenalGuard® U.S. Pivotal Trial 2First Patient Treated in PLC Systems' RenalGuard® U.S. Pivotal Trial 3
(Date:5/20/2013)... Goodman HealthDay Reporter , , SATURDAY, May 18 ... a better view during colonoscopies may help them miss ... shows. Colonoscopies are the recommended screening tests for ... of men and women in the United States. ... tube with a camera mounted on the end called ...
(Date:5/20/2013)... May 20, 2013 A novel service for ... . The company has been in the field of providing ... will make sure that scholars are able to maintain a ... has three stages and has been priced at $1000. , ... dedicated mentor assigned to the project, who will handle all ...
(Date:5/20/2013)... Hiscall Inc. is pleased to announce the ... devices. The Hiscall app includes past, current and future ... and event alerts. , For many, the mobile ... such as the Hiscall Technology Showcase, enabling users to register ... layout. During and after the event users can access ...
(Date:5/20/2013)... Dana R. Hando knows that nails ... experience in a salon, she has seen nails of different shapes, ... article that explains how this small body part can actually serve ... body. A piece from The Huffington Post explains that ... on early warning signs of medical conditions. , Nails that ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 When developing ... gender and personality, are taken into consideration to help ... Researchers have previously determined that there is a clear ... Doc considers the science behind these studies and others ... Now, a new study exploring the effect weight gain ...
Breaking Medicine News(10 mins):Health News:New Device May Show Doctors More of the Colon 2Health News:New Device May Show Doctors More of the Colon 3Health News:Dissertation Clinic Prescribes Customized Remedy for Researchers 2Health News:According to Dana R. Hando, Nails Help to Illustrate Total Body Health 2Health News:According to Dana R. Hando, Nails Help to Illustrate Total Body Health 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New Improved hCG Diet Helping Patient’s Control Eating Impulses 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New Improved hCG Diet Helping Patient’s Control Eating Impulses 3
... ... be conducting a lecture on Radiation Therapy Options For Patients Suffering From Mesothelioma. Her lecture ... ... lecture on Tuesday November 10th, 2009, 5:30 pm CST, MesoCare.org is sponsoring a lecture ...
... SHENZHEN, China, Nov. 6 /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International Limited ... of medical devices worldwide, today announced that it will ... Trade Fair with,Congress in Dusseldorf, Germany from November 18-21, ... more than 40 devices from its three core product,segments: ...
... Amex: CVM ), a developer of vaccines and therapeutics ... late-stage oncology company, announced today that an Institutional Review Board ... has given clearance for the Company,s first clinical study to ... study, which will be led by Principal Investigator Jonathan M. ...
... for better motor skills later, study suggests, , THURSDAY, ... of oxygen at birth often go on to have ... can help prevent problems. , Now, a new study ... brain lesions in the babies. , Oxygen starvation ...
... America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord ... ) focused on bringing the life saving potential ... nationwide and internationally, today addressed shareholder questions about its ... S1 with the SEC, in an interview of Matthew ...
... ... almost anyone to sustain life in the first critical minutes of cardiac arrest. ... vital organs alive until professional rescuers arrive. AED (Automated External Defibrillator) is an ... to a normal heartbeat. AEDs are very accurate and easy to use. With ...
Cached Medicine News:Health News:Mindray Medical to Exhibit at MEDICA 2009 in Dusseldorf, Germany 2Health News:CEL-SCI to Conduct First Clinical Study of Investigational LEAPS-H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University School of Medicine 2Health News:CEL-SCI to Conduct First Clinical Study of Investigational LEAPS-H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University School of Medicine 3Health News:Cord Blood America Updates Advantages of Las Vegas Laboratory in Analyst Interview; Explains Recent S1 Filing 2Health News:A New Era of E-Learning in the Comfort and Convenience of Your Home or Office Without the Classroom Environment 2
... provides anterior column support for single or ... to L5. The system consists of one ... that are stacked to a desired height, ... Fiber Reinforced Polymer material emulates the biomechanical ...
... in interbody fusion are to ... restore disc space height and ... an enviroment for bone fusion ... Allograft is designed to promote ...
... highly adaptable and therefore suitable for a ... its extraordinary small outer diameter and the ... a simple but secure and reliable fixation ... instruments around the corner. These characteristics make ...
A new flexible endoscope with an ultra dense optic fiber system. Its two working and irrigation channels and steering mechanism makes it ideal for a multipurpose use in neurosurgical endoscopy i.e. V...
Medicine Products: